Prevalencia de tumores benignos y malignos en pacientes acromegálicos
Arnez, Lorena; Dalama, Belén; Biagetti, Betina; Mesa, Jordi.
Med. clín (Ed. impr.)
; 145(8): 368-369, oct. 2015.
Artículo en Español | IBECS (España) | ID: ibc-144612
Documentos relacionados
THE PREVALENCE OF CANCER AND ITS RELATION TO DISEASE ACTIVITY IN PATIENTS WITH ACROMEGALY: TWO CENTERS' EXPERIENCE.
Characteristics and treatment outcomes of micromegaly - acromegaly with apparently normal basal GH: A retrospective study and literature review.
The Experience of a Single Tertiary Center Regarding Benign and Malignant Tumors in Acromegalic Patients.
Sex differences in acromegaly at diagnosis: A nationwide cohort study and meta-analysis of the literature.
Post-treatment heterogeneity of cardiometabolic risk in patients with acromegaly: The impact of GH and IGF-1.
Serum biomarkers of colonic polyps in patients with acromegaly: a meta-analysis and systematic review.
Paradoxical GH increase after oral glucose load in subjects with and without acromegaly.
Acromegaly and Cancer: An Update.
Diagnosis, treatment and follow-up of patients with acromegaly in a clinical practice setting in Spain: the ACROPRAXIS program Delphi survey.
Erectile function and androgen and estrogen beta receptor gene polymorphisms in acromegalic men.